HEALTH CANADA: Another conflict of Interest?

In February 2004 Health Canada set up a SCIENTIFIC ADVISORY PANEL on SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRI) and SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS (SNRI).

One key member of that meeting was Dr. Yvon Lapierre.

In 2003, Lapierre wrote a paper entitled 'Suicidality with Selective Serotonin Reuptake Inhibitors: Valid Claim?'

Lapierre's conclusion?

Basically, there is insufficient eveidence that they [SSRis] lead to suicide.

In the small print on the paper you will see that Lapierre has been a consultant to AstraZeneca and Pfizer.

Maybe Lapierre is another Breckenridge?

The similarities are uncanny!

I wrote to Health Canada earlier today requesting a declaration of interests for all those involved in the Scientific Advisory Panel, in particular the following members:

Committee Members Present: Dr. Yvon Lapierre, Dr. Clive Chamberlain, Dr. Jane Garland, Dr. Paul Links, Dr. Aidan Stokes, Dr. Nicole Thibodeau Health Canada (HC)

Working Group Members:
M. Davis (SAP Secretariat Officer, PB), L. Kelly (BCANS), S. Mithani (BCANS), E. Ormsby (SAP Scientific Advisor, PB), C. Petersen (BCANS), Karen Reynolds (BCANS)

I will keep you posted should I get a response.

Fid

Read the new book, The Evidence, However, Is Clear...The Seroxat Scandal

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING